Form 8-K - Current report:
SEC Accession No. 0001104659-21-002477
Filing Date
2021-01-08
Accepted
2021-01-08 16:15:35
Documents
1
Period of Report
2021-01-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm212229d1_8k.htm 8-K 29403
  Complete submission text file 0001104659-21-002477.txt   30642
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 21517635
SIC: 2836 Biological Products, (No Diagnostic Substances)